Cargando…

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease

A number of transcription factors, including En1/2, Foxa1/2, Lmx1a/b, Nurr1, Otx2, and Pitx3, with key roles in midbrain dopaminergic (mDA) neuron development, also regulate adult mDA neuron survival and physiology. Mouse models with targeted disruption of some of these genes display several feature...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blaudin de Thé, François-Xavier, Rekaik, Hocine, Prochiantz, Alain, Fuchs, Julia, Joshi, Rajiv L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736191/ https://www.ncbi.nlm.nih.gov/pubmed/26881122 http://dx.doi.org/10.1155/2016/6097107

Ejemplares similares

Engrailed Homeoprotein Protects Mesencephalic Dopaminergic Neurons from Oxidative Stress
por: Rekaik, Hocine, et al.
Publicado: (2015)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease
por: Giuliano, Claudio, et al.
Publicado: (2021)

Perturbed DNA methylation by Gadd45b induces chromatin disorganization, DNA strand breaks and dopaminergic neuron death
por: Ravel-Godreuil, Camille, et al.
Publicado: (2021)

Homeoprotein Neuroprotection of Embryonic Neuronal Cells
por: Vargas Abonce, Stephanie E., et al.
Publicado: (2019)

Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
por: Palasz, Ewelina, et al.
Publicado: (2019)

Model Identifies Genetic Predisposition of Alzheimer’s Disease as Key Decider in Cell Susceptibility to Stress
por: Stefani, Ioanna C., et al.
Publicado: (2021)

Signaling with Homeoprotein Transcription Factors in Development and Throughout Adulthood
por: Prochiantz, A
Publicado: (2013)

Advances in Neuroprotective Ingredients of Medicinal Herbs by Using Cellular and Animal Models of Parkinson's Disease
por: More, Sandeep Vasant, et al.
Publicado: (2013)

Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
por: Wąsik, Agnieszka, et al.
Publicado: (2015)

Parkinson’s Disease: Overview of Transcription Factor Regulation, Genetics, and Cellular and Animal Models
por: Xia, Ninuo, et al.
Publicado: (2022)

Neuroprotective Effects of Protocatechuic Aldehyde against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease
por: Zhao, Xin, et al.
Publicado: (2013)

Neuroprotection by Nrf2 in Parkinson’s disease model
Publicado: (2011)

Acrolein scavenger dimercaprol offers neuroprotection in an animal model of Parkinson’s disease: implication of acrolein and TRPA1
por: Shi, Liangqin, et al.
Publicado: (2021)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Transcription Factor Nrf2: a novel target to modulate inflammatory and neuroprotective responses in Parkinson’s disease
por: Cuadrado, Antonio
Publicado: (2015)

Astaxanthin is neuroprotective in an aged mouse model of Parkinson’s disease
por: Grimmig, Beth, et al.
Publicado: (2017)

Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
por: Sheng, Xiaoyan, et al.
Publicado: (2021)

Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease
por: Hracskó, Zsuzsanna, et al.
Publicado: (2011)

Neuroprotective properties of curcumin in toxin-base animal models of Parkinson’s disease: a systematic experiment literatures review
por: Wang, Xin-Shi, et al.
Publicado: (2017)

Sequential and directional insulation by conserved CTCF sites underlies the Hox timer in stembryos
por: Rekaik, Hocine, et al.
Publicado: (2023)

Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism
por: Chiu, Ching-Chi, et al.
Publicado: (2014)

Animal Models of Parkinson's Disease
por: Imai, Yuzuru, et al.
Publicado: (2011)

Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease
por: Gonzalo-Gobernado, Rafael, et al.
Publicado: (2020)

Neuroprotective Effects of A Standardized Flavonoid Extract of Safflower Against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease
por: Ren, Rutong, et al.
Publicado: (2016)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

Synthesis and Neuroprotective Action of Xyloketal Derivatives in Parkinson’s Disease Models
por: Li, Shichang, et al.
Publicado: (2013)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease
por: Liang, Yan, et al.
Publicado: (2019)

Neuroprotective potential of Cordia dichotoma in Parkinson's syndrome induced by haloperidol: An animal study
por: Bhavani, Keserla, et al.
Publicado: (2023)

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

The hypoxia imaging agent Cu(II)(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease
por: Hung, Lin W., et al.
Publicado: (2012)

Tianma Gouteng Yin, a Traditional Chinese Medicine decoction, exerts neuroprotective effects in animal and cellular models of Parkinson’s disease
por: Liu, Liang-Feng, et al.
Publicado: (2015)

Neuroprotective Activity of Peripherally Administered Liver Growth Factor in a Rat Model of Parkinson’s Disease
por: Gonzalo-Gobernado, Rafael, et al.
Publicado: (2013)

Engrailed 1 Mediates Correct Formation of Limb Innervation through Two Distinct Mechanisms
por: Huettl, Rosa-Eva, et al.
Publicado: (2015)

Lipopolysaccharide Animal Models for Parkinson's Disease
por: Liu, Mei, et al.
Publicado: (2011)

Animal Models of Parkinson's Disease 2012
por: Imai, Yuzuru, et al.
Publicado: (2012)

Limitations of Animal Models of Parkinson's Disease
por: Potashkin, J. A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7jboq74jo3dbiuo06cfmp4ft13